FibroGen Correlations

FGEN Stock

USD 0.57 0.01 1.72%

The current 90-days correlation between FibroGen and Ardelyx is -0.14 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FibroGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FibroGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

FibroGen Correlation With Market

Average diversification

The correlation between FibroGen and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.

Moving together with FibroGen Stock

0.61	DMAC	DiaMedica Therapeutics	Pair Corr
0.74	DRTS	Alpha Tau Medical	Pair Corr
0.63	SABSW	SAB Biotherapeutics	Pair Corr
0.61	DYAI	Dyadic International	Pair Corr
0.79	SRZNW	Surrozen Warrant	Pair Corr
0.84	VRNA	Verona Pharma PLC	Pair Corr
0.62	VSTM	Verastem	Pair Corr

Moving against FibroGen Stock

0.83	DOMH	Dominari Holdings	Pair Corr
0.74	DNLI	Denali Therapeutics	Pair Corr
0.67	VIGL	Vigil Neuroscience	Pair Corr
0.66	DTIL	Precision BioSciences	Pair Corr
0.6	VINC	Vincerx Pharma	Pair Corr
0.55	DRRX	Durect	Pair Corr
0.5	VERA	Vera Therapeutics	Pair Corr
0.49	DNTH	Dianthus Therapeutics	Pair Corr
0.4	ME	23Andme Holding	Pair Corr
0.38	VANI	Vivani Medical	Pair Corr
0.37	VALN	Valneva SE ADR	Pair Corr
0.34	EQ	Equillium	Pair Corr
0.8	VRTX	Vertex Pharmaceuticals	Pair Corr
0.73	VKTX	Viking Therapeutics	Pair Corr
0.72	EDIT	Editas Medicine	Pair Corr
0.57	VRPX	Virpax Pharmaceuticals	Pair Corr
0.57	ELAN	Elanco Animal Health	Pair Corr
0.56	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.53	VRCA	Verrica Pharmaceuticals	Pair Corr
0.53	VYGR	Voyager Therapeutics	Pair Corr
0.49	EDSA	Edesa Biotech	Pair Corr

Related Correlations Analysis

	ARDX	ZURA	HEPA	AVRO	VSTM	MREO	BPMC	AGIO	DAWN	BMRN
ARDX		0.5	0.32	-0.29	-0.28	0.51	-0.14	0.13	0.42	0.46	ARDX
ZURA	0.5		0.69	-0.62	-0.67	0.88	-0.38	0.42	0.91	0.59	ZURA
HEPA	0.32	0.69		-0.76	-0.36	0.61	-0.3	0.64	0.64	0.31	HEPA
AVRO	-0.29	-0.62	-0.76		0.47	-0.4	-0.01	-0.87	-0.71	-0.01	AVRO
VSTM	-0.28	-0.67	-0.36	0.47		-0.56	0.36	-0.2	-0.58	-0.33	VSTM
MREO	0.51	0.88	0.61	-0.4	-0.56		-0.51	0.23	0.79	0.79	MREO
BPMC	-0.14	-0.38	-0.3	-0.01	0.36	-0.51		0.19	-0.13	-0.63	BPMC
AGIO	0.13	0.42	0.64	-0.87	-0.2	0.23	0.19		0.61	-0.09	AGIO
DAWN	0.42	0.91	0.64	-0.71	-0.58	0.79	-0.13	0.61		0.42	DAWN
BMRN	0.46	0.59	0.31	-0.01	-0.33	0.79	-0.63	-0.09	0.42		BMRN
	ARDX	ZURA	HEPA	AVRO	VSTM	MREO	BPMC	AGIO	DAWN	BMRN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DAWN	+ 0.91	ZURA
MREO	+ 0.88	ZURA
DAWN	+ 0.79	MREO
BMRN	+ 0.79	MREO
HEPA	+ 0.69	ZURA
AGIO	+ 0.64	HEPA

High negative correlations

AGIO	- 0.87	AVRO
AVRO	- 0.76	HEPA
DAWN	- 0.71	AVRO
VSTM	- 0.67	ZURA
BMRN	- 0.63	BPMC
AVRO	- 0.62	ZURA

Risk-Adjusted Indicators

There is a big difference between FibroGen Stock performing well and FibroGen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze FibroGen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ARDX	3.46	(0.15)	0.00	(1.24)	0.00	0.00	8.20	(6.13)	33.99
ZURA	4.55	(1.08)	0.00	(86.41)	0.00	0.00	9.21	(11.55)	26.70
HEPA	4.89	(0.08)	0.00	(0.22)	0.00	0.00	9.33	(8.54)	41.03
AVRO	1.77	0.15	0.05	(0.36)	1.89	(2.24)	4.11	(3.17)	14.20
VSTM	6.10	1.23	0.20	(1.96)	5.36	(7.64)	16.85	(8.35)	50.66
MREO	2.77	(0.62)	0.00	(0.83)	0.00	0.00	4.80	(7.59)	20.77
BPMC	2.09	0.35	0.13	0.42	2.23	(2.27)	5.87	(3.73)	19.12
AGIO	3.06	(0.28)	0.00	(0.33)	0.00	0.00	6.76	(7.01)	31.56
DAWN	1.84	(0.20)	0.00	(0.18)	0.00	0.00	3.92	(3.46)	11.05
BMRN	1.14	(0.20)	0.00	1.78	0.00	0.00	1.29	(3.49)	10.00

FibroGen Corporate Management

Kirk MBA	Chief Officer	Profile
Rahul Kaushik	Technical Development	Profile
Mr JD	Chief Officer	Profile
Enrique Conterno	CEO Director	Profile
Barry Berkowitz	Founder	Profile
Christine Chung	Senior Operations	Profile
David DeLucia	Vice Relations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC